Measure before you treat.
Every other neuro-stim device guesses with presets. Only NeuroReformer® measures each patient first — then treats them with their own frequencies.
Scans, personalizes, and treats — in one guided session.
Outcomes by the numbers.
Not a claim, a chart. Every session in the review was recorded, then read by an independent physician-scientist.
Results describe observed trends over the course of treatment and are not intended to establish causal efficacy or replace controlled clinical studies. Individual outcomes vary.
Trusted by hospitals, leading clinicians, physical therapy and chiropractic practices, professional and university sports teams, and wellness centers.
Real-world evidence reviewed by Matthias R. Schurhoff, MD — Senior Scientist, Baptist Health. White paper publication available upon request.
FOUNDATIONAL LITERATURE Published research on neuromuscular stimulation, impedance, neuromuscular activation, and motor control. Read the literature review →
The full evidence report is on its way to your inbox.
Three clinicians and a scientist went on camera.
Most device pages show anonymous patient quotes. These are surgeons, specialists, and scientists who refer their own patients — on the record.
Independent clinician statements, recorded with permission. Not compensated endorsements of outcomes. Individual results vary.
Two scans. One individualized waveform.
The neurological scan finds where that nervous system communicates most efficiently. The neuromuscular scan finds the waveform producing the strongest contraction.
Both findings resolve into one combined treatment waveform, tuned to that individual. Intensity stays under practitioner control at every step.
Delivered during guided movement, with Adaptive NeuroFrequency Stabilization™ holding the signal steady as the body changes position.
Both systems are patented — the scanning hardware and mapping software behind NeuroFrequency Mapping™, and the signal stabilization behind Adaptive NeuroFrequency Stabilization™.
Not the device you already have.
Most clinics already own electrical stimulation. The question is not whether neuromodulation works — it is what determines the frequencies being delivered.
Characteristics summarized from public manufacturer documentation.
Four sessions a month covers the lease.
No five-figure capital purchase. One monthly lease, everything included — and a typical patient runs nine sessions.
Illustrative example. Practices set their own pricing. Figures are suggested retail and not a projection of revenue.
What every lease includes
Device, training, support, and coverage — everything needed to treat on day one.
The adoption path
Decision-maker in the room for the demo; treating after a 30–40 minute onboarding.
The demo: see it run on your own patients.
A focused demonstration at your clinic, with the right decision-maker in the room — and your patients’ results, in real time.
Now scheduling demonstrations across Florida, expanding regionally through 2026. Outside Florida? Tell us where you are — we’ll arrange a live video demonstration and let you know when we reach your region.
Frequently asked questions
No. TENS delivers a preset current, chosen for the modality. NeuroReformer® measures the individual first — a neurological scan and a neuromuscular scan — then builds one combined treatment waveform from those findings and delivers it during guided movement.
Two things, in that person, on that day: the frequency at which their nervous system communicates most efficiently, and the waveform producing the strongest neuromuscular contraction. Both findings resolve into a single treatment waveform.
Onboarding takes 30–40 minutes, live and recorded. The workflow is screen-guided from scan to documentation, so there are no parameters to dial in, and clinical and technical support is included for the life of the lease.
Yes — FDA-cleared 510(k) Class II, for neuromuscular re-education, increasing local blood circulation, maintaining or increasing range of motion, preventing disuse atrophy, reducing muscle spasms, management of post-surgical, post-traumatic and chronic pain, and preventing venous thrombosis after surgery. Water-immersion delivery via sponge electrode is expressly covered.
Because it is new. The patents were filed within the last few years and adoption has not reached critical mass. The demonstration exists so you can judge it on your own patients rather than on our word.
Leases start at $400 a month and include everything needed to treat on day one — device, training, support, and coverage. The model is cash-pay by design, and practices set their own session pricing.
Pregnancy, pacemakers, and other implantable electrical devices. The provider screens every patient before treatment, and screening is covered in full during onboarding.
A trained provider performs initial setup and treatment planning. Once a session is running, trained staff may monitor it under protocol — which is what makes the economics work in a busy clinic.
No internet is required to treat. The system runs on a rechargeable battery or a standard wall outlet; connectivity is only for software updates, portal access, and syncing session data.